| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Feature |
Division of Endocrinology, Department of Medicine, Baylor College of Medicine (M.M., S.D., D.I., A.R., A.B.); and Endocrine Service, Ben Taub General Hospital (M.M., L.R., A.B.), Houston, Texas 77030; Robert J. Williams Laboratory, Department of Medicine, University of Washington School of Medicine (C.S.H., L.K.G., L.P.H., Å.L.); and Puget Sound Blood Center (L.K.G., D.B.), Seattle, Washington 98195
Address all correspondence and requests for reprints to: Ashok Balasubramanyam, M.D., Division of Endocrinology, BCM 719E, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030. E-mail: ashokb{at}bcm.tmc.edu.
Ketosis-prone diabetes is heterogeneous. Its causes could include novel ß-cell functional defects. To characterize such defects, 103 patients with diabetic ketoacidosis were evaluated for ß-cell autoimmunity and human leukocyte antigen (HLA) class II alleles, with longitudinal measurements of ß-cell function and biochemical and clinical parameters. They were classified into four Aß groups, based on the presence of glutamic acid decarboxylase (GAD)65, GAD67, or IA-2 autoantibodies (A+ or A-) and ß-cell functional reserve (ß+ or ß-). The group distribution was: 18 A+ß-, 23 A-ß-, 11 A+ß+, and 51 A-ß+. Collectively, the two ß- groups differed from the two ß+ groups in earlier onset and longer duration of diabetes, lower body mass index, less glycemic improvement, and persistent insulin requirement. HLA class II genotyping showed that the A-ß- group differed from the A+ß- group in having lower frequencies of two alleles strongly associated with autoimmune type 1 diabetes susceptibility: DQA*03 and DQB1*02. Similarly, the A-ß+ group differed from the A+ß+ group in having a lower frequency of DQB1*02. Ketosis-prone diabetes comprises at least four etiologically distinct syndromes separable by autoantibody status, HLA genotype, and ß-cell functional reserve. Novel, nonautoimmune causes of ß-cell dysfunction are likely to underlie the A-ß+ and A-ß- syndromes.
This work was supported by a Juvenile Diabetes Foundation International Career Development Award, the Chao Scholars Fund, a Siegel Foundation Grant (to A.B.), an American Diabetes Association Career Development Award (to C.S.H.), and National Institutes of Health Grants DK26190 and DK53004 (to Å.L.).
Abbreviations: AUC, Area under the curve; BMI, body mass index; DKA, diabetic ketoacidosis; GAD, glutamic acid decarboxylase; GST, glucagon stimulation test; HbA1c, glycosylated hemoglobin; HLA, human leukocyte antigen; MODY, maturity onset diabetes of youth.
This article has been cited by other articles:
![]() |
A. E. Kitabchi, G. E. Umpierrez, J. M. Miles, and J. N. Fisher Hyperglycemic Crises in Adult Patients With Diabetes Diabetes Care, July 1, 2009; 32(7): 1335 - 1343. [Full Text] [PDF] |
||||
![]() |
W. C. Haaland, D. I. Scaduto, M. R. Maldonado, D. L. Mansouri, R. Nalini, D. Iyer, S. Patel, A. Guthikonda, C. S. Hampe, A. Balasubramanyam, et al. A-{beta}- Subtype of Ketosis-Prone Diabetes Is Not Predominantly a Monogenic Diabetic Syndrome Diabetes Care, May 1, 2009; 32(5): 873 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Waterhouse, I. Sabin, N. Plowman, S. Akker, and T. A Chowdhury A "growing cause" of diabetic ketoacidosis BMJ Case Reports, April 2, 2009; 2009(apr01_2): bcr1120081226 - bcr1120081226. [Abstract] [Full Text] |
||||
![]() |
R. Nalini, L. K. Gaur, M. Maldonado, C. S. Hampe, L. Rodriguez, G. Garza, A. Lernmark, and A. Balasubramanyam HLA Class II Alleles Specify Phenotypes of Ketosis-Prone Diabetes Diabetes Care, June 1, 2008; 31(6): 1195 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balasubramanyam, R. Nalini, C. S. Hampe, and M. Maldonado Syndromes of Ketosis-Prone Diabetes Mellitus Endocr. Rev., May 1, 2008; 29(3): 292 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balasubramanyam and M. Maldonado Accuracy and Predictive Value of Classification Schemes for Ketosis-Prone Diabetes: Response to Fernandez et al. Diabetes Care, September 1, 2007; 30(9): e97 - e97. [Full Text] [PDF] |
||||
![]() |
C. S. Hampe, R. Nalini, M. R. Maldonado, T. R. Hall, G. Garza, D. Iyer, and A. Balasubramanyam Association of Amino-Terminal-Specific Antiglutamate Decarboxylase (GAD65) Autoantibodies with {beta}-Cell Functional Reserve and a Milder Clinical Phenotype in Patients with GAD65 Antibodies and Ketosis-Prone Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 462 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Balasubramanyam, G. Garza, L. Rodriguez, C. S. Hampe, L. Gaur, A. Lernmark, and M. R. Maldonado Accuracy and Predictive Value of Classification Schemes for Ketosis-Prone Diabetes Diabetes Care, December 1, 2006; 29(12): 2575 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, and R. A. Kreisberg Hyperglycemic Crises in Adult Patients With Diabetes: A consensus statement from the American Diabetes Association Diabetes Care, December 1, 2006; 29(12): 2739 - 2748. [Full Text] [PDF] |
||||
![]() |
G. E. Umpierrez Ketosis-Prone Type 2 Diabetes: Time to revise the classification of diabetes Diabetes Care, December 1, 2006; 29(12): 2755 - 2757. [Full Text] [PDF] |
||||
![]() |
C. Sze, D. Gould, G. Hitman, and T. A Chowdhury Relapsing and remitting insulin requiring diabetes: type 1 or type 2? J R Soc Med, August 1, 2006; 99(8): 415 - 416. [Full Text] [PDF] |
||||
![]() |
G. E. Umpierrez, D. Smiley, and A. E. Kitabchi Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med, March 7, 2006; 144(5): 350 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Hannon, G. Rao, and S. A. Arslanian Childhood Obesity and Type 2 Diabetes Mellitus Pediatrics, August 1, 2005; 116(2): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mauvais-Jarvis, S. B. Smith, C. L. May, S. M. Leal, J.-F. Gautier, M. Molokhia, J.-P. Riveline, A. S. Rajan, J.-P. Kevorkian, S. Zhang, et al. PAX4 gene variations predispose to ketosis-prone diabetes Hum. Mol. Genet., December 15, 2004; 13(24): 3151 - 3159. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rasouli and S. C. Elbein Improved Glycemic Control in Subjects with Atypical Diabetes Results from Restored Insulin Secretion, But Not Improved Insulin Sensitivity J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6331 - 6335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tanaka, T. Endo, K. Aida, H. Shimura, N. Yokomori, M. Kaneshige, F. Furuya, S. Amemiya, M. Mochizuki, K. Nakanishi, et al. Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA1c Levels at Onset Diabetes Care, August 1, 2004; 27(8): 1936 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kitabchi Ketosis-Prone Diabetes--A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes? J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5087 - 5089. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |